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ABSTRACT
Objective: The main purpose of this study was to develop a topical delivery of itraconazole to reduce the dose of the drug, to improve patient 
compliance, and to avoid the side effects. Itraconazole is a triazole derivative to treat antifungal and antiprotozoal infections.
Methods: Topical gel formulations of itraconazole were prepared using Carbopol 940 as a gelling agent with different concentrations. Four different 
formulations were prepared and evaluated with respect to color, spreadability, viscosity measurement, determination of pH, drug content, in vitro 
drug release studies, zeta potential studies, and stability studies. Compatibility study was carried out by Fourier-transform infrared (FT-IR) spectral 
analysis.
Results: FT-IR study revealed that there were no significant interaction between the drug and polymers. All the prepared formulations show 
acceptable physical properties. The drug content and percentage yield were higher for F1 formulation among all formulation F1 shows better drug 
release. Stability study of best formulation shows that there was no difference in drug content and in vitro drug release studies.
Conclusion: From the above observation results that this formulation may be more encouraging topical substitute for the healing of fungal infections 
in the skin.
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INTRODUCTION
Topical drug administration is one of the localized drug delivery 
system given through ophthalmic, vaginal, rectal, and skin as topical 
routes. Topical route of drug delivery system has attained popularity 
as it avoids first-pass effects, gastrointestinal irritation, and metabolic 
degradation associated with oral administration. Due to the first past 
effect only 25-/45% of the orally administered dose reaches the blood 
circulation. In order to bypass these disadvantages the gel formulations 
have been proposed as topical application [1]. Topical gel formulations 
give an appropriate distribution system as they are less greasy and 
straightforward to get rid of the skin.
Nowadays, the dermatological complication majorly caused due to 
fungal infection. The medical practitioner has mentioned treatment 
through following dosage formulations such as solid, liquid, and 
semi-solid [2]. Transparent gels are broadly used topical formulations 
in both cosmetics and pharmaceuticals.
The drug is applied to the mucous membrane or skin that may enhance 
the skin simple operate and alters its action. Those products are called 
topical or dermatological products.
We must know the skin anatomy, physiology, and physicochemical 
properties and it is used for the percutaneous absorption [3]. 
Skin is made up of three layers: Dermis, epidemi, and hypodermis 
(subcutaneous layer). The width of epidermis is 0.1–1.5 mm and it has 
five division: Stratum basale, stratum spinosum, stratum granulosum, 
stratum lucidum, and stratum corneum [4]. Epidermis secretes 
melanin from melanocytes. The squamous cell layer is the widest 
layer that moves irrefutable substances inside and outside of the body.
MATERIALS AND METHODS
Materials
Itraconazole was acquired from Sigma-Aldrich, Chennai, India. Carbopol 
was obtained from Sigma-Aldrich, Chennai, India. All Other Chemicals 
used were of the standard analytical grade.
Method of preparation of topical gel containing itraconazole
Topical gel formulations were prepared using various concentration 
of polymer Carbopol 940 is dispersed in cozy water with constant 
stirring by magnetic stirrer at a medium pace. Required amount of 
drug is dissolved with propylene glycol, and it was neutralized with 
triethanolamine of sufficient quantity in it with constant stirring [3]. 
Glycerin and propylparaben are added little by little with constant 
stirring until it forms a homogeneous gel. Gels are packed in a wide-
mouthed glass jar, and it is covered with screw copped plastic lid after 
covering with aluminum foil [5,6]. Various preparations of itraconazole 
topical gel are shown in Table 1. They were kept in the dark and cool 
place.
Evaluation of physicochemical parameters of prepared itraconazole 
gel
Drug-excipients compatibility studies
Fourier transfer infrared spectrophotometer (FTIR)
The drug, polymer, and excipient interactions are studied using the 
FTIR method. In general, drug and excipients must be coinciding with 
each other which produce a stable, safe, and efficacious product. IR 
spectral analysis of pure drug and polymers was transported out [7]. 
Pure drug that gives peak and patterns were compared with the peaks 
and patterns with the combination of polymer and drug.
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Zeta potential
Zeta potential is the measurement of attraction or repulsion in 
between particles. Its measurement brings details about the dispersion 
mechanism which is used to measure electrostatic dispersion [8].
The zeta potential calculation is a important limitation across a various 
range of industries incorporates pharmaceuticals, brewing, medicine, 
ceramics, and water treatment. For colloidal stability, the repulsive 
forces between two particles should be ascendant [9]. Zeta potential 
is a useful index of magnitude for interaction between colloidal 
particles. In general, the colloidal systems stability is determined using 
measurements based on zeta potential.
Visual properties
A physical property of the gel formulations was determined by visual 
observation for their color, uniformity, transparency, and phase 
separation. The prepared gels show uniformity without clumps [10].
Determination of pH
The digital pH meter is used to find out the pH value of a formulated 
topical gel. The values of prepared formulations are between the ranges 
of 4–8 that ignores the chance of skin irritation [11].
Spread ability
The assessment of spread capacity, two glass slides were taken, and the 
prepared gel was compressed in between the two glass slides to steady 
stability by applying weight and leaves it for 6 min [12]. The value of 
spreadability is gathered by determining the time taken for the two 
glass slides to get separated.
Percentage yield
The practical yield of each sample is determined by weighing the 
empty container and the container along with the gel formulation 
and subtraction of empty container with the container along with the 
gel [9].
Uniformity of drug content
The expression “uniformity of dosage unit” is explained as the 
substances degree of uniformity among dosage units. The content 
uniformity test depends on the assay of the active medicament. 100 mg 
of the formulated gel is taken and dissolved in 100 ml of phosphate 
buffer of pH 6.8. The above solution is allowed to stand for 30 min 
followed by gentle stirring to enhance the solubility of the drug [13]. 
Then, it is treated, and the absorbance of the solution was identified 
spectrophotometrically at 296 nm using phosphate buffer pH 6.8 as 
blank.
Grittiness
The existence of particles in the formulations was determined 
microscopically [14], if there is no specific matter when observed under 
light microscope.
Viscosity estimation
Alteration in viscosity of the product displays adjustment instability 
and efficacy of the product. Uniformity of formulation lies on the 
ratio of the solid fraction to liquid fraction which constructs gel 
structure [15]. The viscosity of topical gels was acquired using Brook-
Field viscometer DE-V model using spindle no 61 and spindle speed of 
50 rpm at 37°C.
In vitro drug release
Franz-diffusion cells equipment is used to study the in vitro drug 
release using various formulations [16]. The specific quantity of 
formulation was applied on the membrane positioned between the 
donor and receptor chambers with an available diffusion area. Fill 
the receptor chamber with phosphate buffer pH 6.8 and is blended 
repeatedly with a tiny magnetic bead, the speed of 50 rpm is continued 
at the temperature at 37°C±2°C. At different meantime, the samples 
were taken and then it is exchanged with the same volume of phosphate 
buffer pH 6.8 to maintain the volume of dissolution medium [11]. In all 
cases, sink conditions are seen. The obtained samples were analyzed 
spectrophotometrically at 296 nm.
Stability study
The concentration of an active ingredient of all formulation may fall 
with upraise in the temperature and time. This assists in drop in the 
potency of the product. Stability study in various temperatures ought to 
be dispensed to anticipate the formulation stability.
Stability studies are strenuous at regulating the outcome of aging and 
storage under divers circumstance on the formulated gel. Stability 
studies take place to detect whether any chemical breakdown of 
itraconazole formulations take place or not [17]. The chief formulation 
was kept at 30±2°C and 40±2°C at RH 65±5 and 75±5 RH for 2 months 
in a glass vial. After 1 or 2 months, the samples were repeatedly tested 
for the drug content and in vitro release studies.
RESULTS AND DISCUSSION
Drug-excipients compatibility studies
The IR studies of clear Itraconazole formulation comprises greater 
proportion of the polymers that are conducted to know about the bond 
between the used polymers and the drug. The outcome is represented 
in Figs. 1-3.
The IR spectrum of pure itraconazole and itraconazole gel formulations 
that posses greater proportion of polymer that gives comparable basic 
patterns and peaks. Outcome status that no notable drug and polymer 
interactions.
Visual inspection
Visual determination is done to examine the syneresis and color of 
the developed formulation. The preparations must be logical and 
translucent. Eventually, the formulated gel shows better homogeneity 
without any lumps and syneresis.
Determination of pH
The pH value of all developed gel was in the range of 6.6–7.1. This is 
sufficient for appealing to skin and avoid the chances of irritation. The 
outcome is available in Table 2.
Spreadability
The study has a few major elements that show the gel character that 
emerges out from the tube. The values of spreadability are given 
in Table 2. Spreadability test is carried for all the formulations. 
Spreadability of the gel formulation drops with respect to increase in 
the polymer concentration.
Determination of drug content
The drug content of the formulated gel was estimated. Results are 
represented in Table 2. The drug content manifests that the drug was 
distributed equally throughout the gel.
Percentage yield and viscosity
Percentage yield of a topical gel consisting of itraconazole was in the 
range of 96.89–98.87%. The values are stated in Table 3. This was 
identified that the percentage yield of F2 formulation showed an increase 
Table 1: Formulation of itraconazole topical gel
Ingredients F1 F2 F3 F4
Itraconazole 1 1 1 1
Carbopol 940 1 1.5 2 2.5
Propylene glycol 3 3 3 3
Propylparaben 0.01 0.01 0.01 0.01
Glycerin 10 10 10 10
Triethanolamine 4 4 4 4
Water up to 100 100 100 100
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Fig. 1: Fourier-transform infrared spectrum of itraconazole
Fig. 2: Fourier-transform infrared spectrum of Carbopol 940
Table 2: pH, spreadability, and drug content of 
formulations (F1-F4)
Formulation code pH Spreadability (g.cm2) Drug content %
F1 7.1 10.75 98.67±0.021
F2 6.8 11.08 96.32±0.012
F3 6.9 11.75 97.43±0.024
F4 6.6 10.25 96.01±0.018
Table 3: Percentage yield and viscosity of different 
formulations (F1-F4)





Table 5: Zeta potential (sample)
Peak no. Zeta potential Electrophoretic mobility
1 14.4 mV −0.000029 cm2/Vs
2 0.00 mV 0.00 cm2/Vs
3 0.00 mV 0.00 cm2/Vs
Zeta potential (mean): −14.4 mV. Electrophoretic mobility 
mean: −0.000029 cm2/vs
Table 4: Zeta potential (standard)
Peak no. Zeta potential Electrophoretic 
mobility
1 14.4 mV −0.000016 cm2/Vs
2 0.00 mV 0.00 cm2/Vs
3 0.00 mV 0.00 cm2/Vs
Zeta potential (mean): −2.0 mV. Electrophoretic mobility 
mean: −0.000016 cm2/Vs
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Fig. 3: Fourier-transform infrared spectrum of drug + polymer
Fig. 4: Measurement of zeta potential (standard)
Table 6: Comparative dissolution study of different formulations 
with various ratios of polymers
S.No Time (min) % Drug release
F1 F2 F3 F4
1 30 10.96 9.54 11.45 8.90
2 60 25.56 21.07 22.79 20.06
3 90 38.12 33.91 35.41 34.55
4 120 52.23 45.44 47.33 48.23
5 150 64.45 59.71 57.21 60.10
6 180 75.07 72.23 70.39 71.86
7 210 85.34 82.86 80.05 83.24
8 240 90.33 89.96 88.80 91.49
9 270 96.12 98.72 99.01 99.34
in percentage yield than the other preparation. In general, consistency of 
formulation depends on the ratio of the solid fraction to liquid fraction 
which produces gel structure. The data are presented in Table 3.
Zeta potential for standard (water)
A zeta potential value of standard (water) is stated in Table 4, and the 
crown depiction of the data is shown in Fig. 4.
Zeta potential for sample
Zeta potential values of the formulation sample are expressed in 
Table 5, and the crown depiction of the data is shown in Fig. 5.
In vitro drug release
The drug release profile of itraconazole topical gel formulations was 
accomplished by diffusion cell. As an outcome of the in vitro release 
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Fig. 5: Measurement of zeta potential (sample)
Table 7: Stability study of F1 optimized formulation
S.No Time (mins) 0 Days Percentage % drug release
30 days 60 days
30±2C 40±2C 30±2C 40±2C
1 30 10.96 10.95±0.12 10.95±0.01 10.94±0.14 10.94±0.12
2 60 25.56 25.54±0.11 25.51±0.81 25.54±0.41 24.96±0.19
3 90 38.12 38.0±0.94 38.1±0.91 37.9±0.81 37.6±0.12
4 120 52.23 52.21±0.41 52.19±0.13 52.0±0.12 51.96±0.21
5 150 64.45 64.43±0.16 64.19±0.27 64.12±0.41 64±1.56
6 180 75.07 75.0±1.06 74.91±1.27 74.71±1.52 74.6±1.89
7 210 85.34 85.21±0.14 85.2±0.09 85.16±0.41 85.12±1.2
8 240 90.33 90.32±0.132 90.21±1.35 90.19±1.89 90.13±1.161
9 270 96.12 96.96±1.72 94.69±1.47 96.62±1.12 95.59±1.37
Table 8: Drug content estimation after storing at different temperatures (F1)
S.No Formulation Drug content
30±2C 40±2C
30 days 60 days 30 days 60 days
1 F1 98.01±0.01 97.48±0.02 98.39±0.01 97.87±0.06
studies of all formulations are given in Table 6, and the statistically 
represented is shown in Fig. 6.
The percentage drug release of all formulations after 4.5 h using 
Carbopol was identified to be 96.12% (F1), 98.72% (F2), 99.01% (F3), 
and 99.34% (F4), respectively. The most essential factors in the drug 
release are the type of polymer by the concentration of polymer.
Stability study
There was no noticeable difference in the in vitro drug release study 
F1 (from 96.96% to 96.62%) at 30±2°C at 65±5 RH. After storing at 
40±2°C at 75±5 RH the in vitro drug release study of F1 formulation is 
decreased. The statistics are stated in Table 7. This was discovered that 
the developed itraconazole gel formulae and its storage were identified 
to be firm for 2 months at room temperature; there were no changes in 
the specification that is inflated such as physical aspect as color, drug 
content, and drug release during the inspection.
Stability studies were carried for the most effective formulation-F1, at 
30±2°C and 40±2°C at 65±5 and 75±5 RH for 2 months. At the end of 
2 months, samples were evaluated. Drug content study showed that 
there was no major change in the content drug of F1 (from 98.01% 
to 98.39%) at 30±2°C at 65±5 RH and decrease at 40±2°C at 75±5 RH 
(from 97.48% to 97.87%). The data are presented in Table 8.
DISCUSSION
The triazole derivative of itraconazole is one of the best drugs 
suited for the treatment of fungal infections. In this study, the 
topical gel preparation of itraconazole was formulated for efficient 
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that transports the drug across the skin. UV spectrophotometry 
surveys of prepared itraconazole gel manifest the absorption at the 
wavelength of 269 nm. The utility of the associated coefficient was 
endowed to be R² = 0.9998, that obeys beers law. The obtained FTIR 
peaks showed the drug-excipients compatibility. Different ratio of 
the formulation (F1, F2, F3, and F4) was advanced using suitable 
polymer (Carbopol 940p) and infiltration enhancer. Advanced 
formulations of itraconazole were analyzed for physiochemical 
parameters such as viscosity, spreadability, drug content, and in vitro 
drug release studies. From all the build out formulation, F1 manifest 
drug liberates for a phase of 4.5 h. The most efficient formulation of 
F1 shows a significant change in drug contents. The formulated drug 
stability was monitored for 2 months at 30±2°C and 65± 5 RH. It was 
found that the drug showed good stability at the opted appropriate 
condition.
CONCLUSION
By bearing the above result, we able to conclude that our drug 
itraconazole was incorporated with success into the topical gel 
construction among all the built formulation the formulation F1 manifest 
better spreadability, drug content, viscosity, and drug liberation studies. 
Therefore, this was ceased that our formulation would be very assuring 
topical alternative for the treatment of skin fungal infections.
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